| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |